Aging or comorbid conditions - What is the main cause of kidney damage?

Journal of Nephrology

Volumn 23, Issue 4, 2010, Pages 444-452

  Król, Ewa ^a   Rutkowski, Bolesław ^a   Czarniak, Piotr ^a   Kraszewska, Ewa ^b  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

Author keywords

Aging; Albuminuria; Diabetes; Hypertension; Obesity; Smoking

Indexed keywords

ADULT; AGED; AGING; ALBUMINURIA; ARTICLE; CHRONIC KIDNEY DISEASE; CIGARETTE SMOKING; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GROUPS BY AGE; HUMAN; HYPERTENSION; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; POLAND; POPULATION RESEARCH; PREDICTION; SEX DIFFERENCE; ADOLESCENT; CHRONIC DISEASE; COMPLICATION; DIABETES COMPLICATIONS; KIDNEY DISEASES; MIDDLE AGED; OBESITY; SMOKING; STATISTICAL MODEL; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; ALBUMINURIA; CHRONIC DISEASE; COMORBIDITY; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPERTENSION; KIDNEY DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY; SMOKING;

EID: 77955442527     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Garg AX, Kiberd BA, Clark WF, Haynes RB, Clase CM. Albuminuria and renal insufficiency prevalence guides population screening: Results from the NHANES III. Kidney Int. 2002;61:2165-2175.
2. Coresh J, Astor B, Greene T, Eknoyan G, Levey A. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1-12.
3. Atkins RC, Polkinghorne KR, Briganti EM, Shaw JE, Zimmet PZ, Chadban SJ. Prevalence of albuminuria in Australia: the AusDiab Kidney Study. Kidney Int Suppl. 2004;(92):S22-S24.
4. Polkinghorne K, Su Q, Chadban S, Shaw J, Zimmet P, Atkins R. Population prevalence of albuminuria in the Australian Diabetes, obesity, and lifestyle (AusDiab) study: immunonephelometry compared with high performance liquid chromatography. Am J Kidney Dis. 2006;47:604-613.
5. Wen CP, Cheng TY, Tsai MK, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462293 adults in Taiwan. Lancet. 2008;371:2173-2182.
6. Rutkowski B, Czekalski S, Sułowicz W, et al. Epidemiology of kidney diseases in Poland - pilot study (PolNef). Przegl Lek. 2004;61:22-24.
7. Król E, Rutkowski B, Czekalski S, et al. Early diagnosis of renal diseases - preliminary results from the pilot study PolNef. Przegl Lek. 2005;62:690-693.
8. Rutkowski B, Król E. Epidemiology of chronic kidney disease in Central and Eastern Europe. Blood Purif. 2008;26:381-385.
9. Król E, Rutkowski B, Czarniak P, et al. Early detection of chronic kidney disease: results of the PolNef Study. Am J Nephrol. 2009;29:264-273.
10. Konta T, Hao Z, Abiko H, et al. Prevalence and risk factor analysis of microalbuminuria in Japanese general population: the Takahata study. Kidney Int. 2006;70:751-756.
11. Cirillo M, Laurenzi M, Mancini M, Zanchetti A, Lombardi C, De Santo NG. Low glomerular filtration in the population: prevalence, associated disorders, and awareness. Kidney Int. 2006;70:800-806. (Pubitemid 44215358)
12. Kausz AT, Guo H, Pereira BJ, Collins AJ, Gilbertson DT. General medical care among patients with chronic kidney disease: opportunities for improving outcomes. J Am Soc Nephrol. 2005;16:3092-3101.
13. Tonelli M, Wiebe N, Culleton B, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006;17:2034-2047.
14. Foley RN, Murray AM, Li S, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol. 2005;16:489-495.
15. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc. 1985;33:278-285.
16. Hemmelgarn BR, Zhang J, Manns BJ, et al. Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int. 2006;69:2155-2161.
17. Jaber BL, Madias NE. Progression of chronic kidney disease: can it be prevented or arrested? Am J Med. 2005;118:1323-1330.
18. Morita S, Fukuhara S, Akizawa T, et al. Prognostic factors for a composite end-point of renal outcomes in patients with chronic kidney disease. Ther Apher Dial. 2006;10:72-77.
19. O'Hare AM, Choi AL, Bertenthal D, et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol. 2007;18:2758-2765. (Pubitemid 47531203)
20. Garg AX, Papaioannou A, Ferko N, Campbell G, Clarke JA, Ray JG. Estimating the prevalence of renal insufficiency in seniors requiring long-term care. Kidney Int. 2004;65:649-653. (Pubitemid 38130661)
21. Eriksen BO, Ingebretsen OC. The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int. 2006;69:375-382.
22. Locatelli F, Pozzoni P. Chronic kidney disease in the elderly: is it really a premise for overwhelming renal failure? Kidney Int. 2006;69:375-382.
23. O'Hare AM, Bertenthal D, Covinsky KE, et al. Morality risk stratifaction in chronic kidney disease: One size for all ages? J Am Soc Nephrol. 2006;17:846-853.
24. Jager KJ, van Dijk PC, Dekker FW, Stengel B, Simpson K, Briggs JD. The epidemic of aging in renal replacement therapy: an update on elderly patients and their outcomes. Clin Nephrol. 2003;60:352-360.
25. Rutkowski B. Highlights on the epidemiology of renal replacement therapy in Central and Eastern Europe. Nephrol Dial Transplant. 2006;21:4-10. (Pubitemid 43057098)
26. Rutkowski B, Lichodziejewska-Niemierko M, Grenda R, Czekalski S, Durlik M, Bautembach S. Report on the renal replacement therapy in Poland - 2006. Gdansk: Polish Renal Registry; 2008.
27. Kawecka A, Król E, Przekwas M, Dȩbska-Ślizień A, Rutkowski B. Elder patients - what is the best vascular hemodialysis access? JAVA (Journal of the Association for Vascular Access). 2008;13:75-80.
28. US Renal Data System. USRDS 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2007.
29. Król E, Czarniak P, Rutkowski B. Hypertension and chronic kidney disease. Results of Program for Early Detection of Chronic Kidney Disease in Poland (PolNef). Nadciśnienie Tȩtnicze. 2007;11:114-122.
30. Król E, Czarniak P, Rutkowski B. Effectiveness of antihypertensive treatment in patients with chronic kidney disease. J Ren Nutr. 2008;18:134-139. (Pubitemid 350251842)
31. WHO Report. 2002: Reducing risk, promoting healthy life. Geneva: World Health Organization; 2002.
32. Murray CJ, Lopez AD. The global burden of the disease. Cambridge, MA: Harvard School of Public Health; 1996.
33. McLachlan MSF, Guthrie JC, Anderson C, Fulker M. Vascular and glomerular changes in the ageing kidney. J Pathol. 1977;121:65-78.
34. Furci L, Baraldi A, Medici G, Maccari D, Lusvarghi E. Nephropathies in the elderly. An epidemiological study. Contrib Nephrol. 1993;105:157-160.
35. Rutkowski B. Structural and functional disorders in kidneys of elderly people. Gerontologia Polska. 2005;13:211-217.
36. Wieczorowska-Tobis K. Organ alterations due to aging. Pol Arch Med Wewn. 2008;118(Suppl):63-69.
37. Douville P, Martel AR, Talbot J, Desmeules S, Langlois S, Agharazii M. Impact of age on glomerular filtration estimates. Nephrol Dial Transplant. 2009;24:97-103.
38. Rutkowski B, Pempkowiak L, Muszkowska-Penson J, Manitius A. Impaired urine acidification in persons of advanced age. Acta Med Pol. 1980;21:121-128.
39. Chodorowski Z, Rutkowski P, Rutkowski B, Sein Anand J. Effects of age and low sodium diet on glomerular filtration rate, plasma renal flow, urinary aldosterone excretion rate and ability of renal sodium conservation in the elderly. New Medicine. 2003;6:94-96.
40. Fox CS, Larson MG, Leip EP, Gulleton B, Wilson PW, Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA. 2004;291:844-850.
41. De Jong PE, Hillege HL, Pinto-Sietsma SJ, de Zeeuw D. Screening for microalbuminuria in the general population: a tool to detect subjects at risk for progressive renal failure in an early phase? Nephrol Dial Transplant. 2003;18:10-13.
42. Halbesma N, Brantsma A, Bakker S, et al. Gender differences in predictors of the decline of renal function in the general population. Kidney Int. 2008;74:505-512.
43. Zoccali C, Mallamaci F. Obesity, diabetes, adiponectin and the kidney: a podocyte affair. Nephrol Dialysis Transplant. 2008;23:3767-3770.
44. Praga M. Synergy of low nephrons number and obesity: a new focus on hyperfiltration nephropathy. Nephrol Dial Transplant. 2005;20:2594-2597.
45. Wolf G, ed. Obesity and the kidney. Contrib Nephrol. Basel: Karger 2006;151:1-15.
46. Williams PJ, Kurlak LO, Perkins AC, et al. Hypertension and impaired renal function accompany juvenile obesity: the effect of prenatal diet. Kidney Int. 2007;72:279-289.
47. Weisinger JR, Kempson RL, Eldridge FL, Swenson RS. The nephrotic syndrome: a complication of massive obesity. Ann Intern Med. 1974;81:440-447.
48. Kasiske BL, Crosson JT. Renal disease in patients with massive obesity. Arch Intern Med. 1986;146:1105-1109.
49. Rutkowski P, Klassen A, Sebekova K, Bahner K, Heidland A. renal disease in obesity: the need for greater attention. J Ren Nutr. 2006;16:216-223. (Pubitemid 43975009)
50. Serra A, Romero R, Lopez D, et al. Renal injury in the extremely obese patients with normal renal function. Kidney Int. 2008;73:947-955.
51. Orth SR, Stöckmann A, Conradt C, et al. Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int. 1998;54:926-931.
52. Stengel B, Couchoud C, Cenee S, Hemon D. Age, blood pressure and smoking effects on chronic renal failure in primary glomerular nephropathies. Kidney Int. 2000;57:2519-2526. (Pubitemid 30340750)
53. Halimi JM, Giraudeau B, Vol S, et al. Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population. Kidney Int. 2000;58:1285-1292.
54. Cignarelli M, Lamacchia O, Di Paolo S, Gesualdo L. Cigarette smoking and kidney dysfunction in diabetes mellitus. J Nephrol. 2008;21:180-189.
55. Grassi G, Arenare F, Pieruzzi F, Brambilla G, Mancia G. Sympathetic activation in cardiovascular and renal disease. J Nephrol. 2009;22:190-195.
56. Jousilahti P, Vartiainen E, Puska P. Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective followup study of 14786 middle-aged men and women in Finland. Circulation. 1999;99:1165-1172.
57. Jousilahti P, Tuomilehto J, Puska P. Twenty-year dynamics of serum cholesterol levels in the middle-aged population of eastern Finland. Ann Intern Med. 1996;125:713-722. (Pubitemid 126450358)